Navigation Links
EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
Date:1/28/2008

peak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).

Contact:

Ginny Dunn

Associate Director, Corporate Communications & Investor Relations

EntreMed, Inc.

240.864.2643


'/>"/>
SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
2. EntreMed Appoints Senior Vice President of Research and Development
3. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
4. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. BAI Retail Delivery Conference Softpro Presents Next Generation Signature Tablet
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
9. Arpida Presents Preclinical Data on AR-2474 at ICAAC
10. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
11. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRN...in Africa: Everyone,s Problem and Heritage" ,...diversity, 2-3 June 2010 the,Gabonese Republic is ...(Gabon) on the issue of safeguarding biological re... by government and state leaders, ministers,scien...
(Date:12/2/2009)..., , JERUSALEM, Israel, December ...asibility study evaluating the preclinical (animal...uct which combines technology from Weill,Cornell M...ve potential to,treat inherited anemias such as Co...g a series of technologies to expand, ex vivo,pop...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswi..." or the "Company") (NYSE: SCR ), a leading phar..., manufacturing, and marketing of branded,generic ...nounced that 105 of,its drugs have been included i...), which was issued by China,s Ministry of Human R...
(Date:12/2/2009)... The Scientist, a leading ...nked Photometrics’ Evolve “Intelligent...rsquo;s “Top 10 Innovations of 2009. , ...e Evolve ™ EMCCD camera from Photometrics...mance CCD and EMCCD cameras for the life sciences,...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
...at real change in how things are done inside a cor...ed first. But corporate culture is a difficult thi...t reflects the implicit values, norms and behavior...tive and value creating behavior it can give a com...k anybody working for an organization like Southwe...
...ucts are not the only ones that can be inspected b... FDA also inspects clinical trial sites (studies i...t animal, plant or microorganism studies used in F..., ,FDA enforces many regulations that affect clini...oratory practices, good clinical practices, human ...
...on people on the Internet, 30 percent of whom are ... in Asia will be playing with e-commerce. All that...enomenal rate will create global shockwaves both i...t of Asia, including India and several other highl...ess of this advance is still hard to imagine by We...
Other Biology Technology:Why corporate culture counts 2Why corporate culture counts 3Why corporate culture counts 4Who's that knocking at the door? Preparing for an FDA inspection 2Who's that knocking at the door? Preparing for an FDA inspection 3Who's that knocking at the door? Preparing for an FDA inspection 4Huge cyber-tsunami developing in Asia 2Huge cyber-tsunami developing in Asia 3
(Date:12/3/2009)...d adapt to changes in our daily environment, as we...in the minute junctions where nerve cells communic...ine Center researchers. The study is published onl...ientists, led by Wen-Biao Gan, PhD, associate prof... of Medicine, discovered that a delicate balancing...
(Date:12/3/2009)...TRC-AACR San Antonio Breast Cancer Symposium conti...and world leaders from industry and academia with ...ear, more than 8,500 scientists and other professi...ion Center in San Antonio from Dec. 9-13, 2009. Th...Association for Cancer Research, the University of...
(Date:12/3/2009)...al snubbing? Your genetics, not your friends, may ...pium-like painkillers, called opioids, relieve not...nal stress. Now, a new study reviewed by Faculty o...ll genetic differences in the gene for the opioid ...esponses to social rejection. , In the study pu...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2HMS Acquires IntegriGuard to Expand Program Integrity Capabilities 58521 1HMS Acquires IntegriGuard to Expand Program Integrity Capabilities 58521 2Premier Heart Launches Multifunction CardioGram 28TM 29 28MCG 29 In Latin America and the Caribbean 5099 1Premier Heart Launches Multifunction CardioGram 28TM 29 28MCG 29 In Latin America and the Caribbean 5099 2PAREXEL International to Present at William Blair Emerging Growth Stock Conference 5096 1PAREXEL International to Present at William Blair Emerging Growth Stock Conference 5096 2
...ation for Molecular Pathology (AMP) announced toda...ties Union (ACLU) and the Public Patent Foundation...uman genes associated with breast and ovarian canc... Individuals with certain mutations along these tw...icantly higher risk for developing hereditary brea...
...pions cutting-edge medical research, a biomedical ... developing a new treatment for infants born with ...o prematurely fuse together. , The new approach i...s biodegradable and bio-absorbable. If successful,...s problematic bone fractures in adults, such as th...
... , Researchers of the University of Granada h... driven look up table based simulator,), which per...ystem, such as the retina, the cerebellum, the hea...ic advance permits to analyze and understand the f...to new pathologies and diseases or test new medici...
Other Biology News:Association for Molecular Pathology joins ACLU to challenge gene patents 2UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants 2Development of an artificial simulator of the nervous system to do research into diseases 2
...t precision, more user-friendliness and absolute r...is the definition of the Mastercycler ep system. I...n developing dynamically. The same applies to the ...e with these technological advances, the challenge...
...or easy transformation of the budding yeast, Sacch...ansformation simply by mixing a plasmid DNA and th...icated steps, such as centrifugation or cell washi...ted for high-throughput transformation of a large ...
...es your life easier. It offers a wide array of fea... for one balance. *Instruments supported: C...PR, SR, PG-S, PG, SG, AT, MT, UMT, AB-S, PB-S, PB-... the balance display *Execute weighings directly ...
... ,Components g/500 ml: ,Tryptone 5.0 ,Yea...,S-Gal 0.125 ,Ferric ammonium citrate 0.250 ,...ycin/LB Agar Blend is a complete growth medium con...pyranoside, a patented autoclavable chromogenic su...
Biology Products: